prostate-cancer

Documents about prostate-cancer

• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer#283048ClinicalTrials.gov
• A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy#329539ClinicalTrials.gov
• Integrating network toxicology, machine learning, and single-cell sequencing to reveal the FASN-mediated role of phenolic endocrine disruptors in water in promoting prostate cancer.#255226NCBI PubMed Central
• Vitamin E TPGS-emulsified poly-ε-caprolactone nanoparticles increase curcumin in vitro cytotoxic effect and inhibitory metastatic characteristics in prostate cancer cells#260416Repositório Institucional Unesp
• Improving physical activity in men with prostate cancer through wearable devices and online education: Randomized controlled trial.#276002PubMed
• Theory-based dyadic co-learning intervention to enhance family resilience in men with prostate cancer and their spouses in Taiwan: protocol for a randomised controlled trial.#322818NCBI PubMed Central
• A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies#343826ClinicalTrials.gov
• Change in Adherence to Oral Antidiabetic Medications Before and After Prostate Cancer Diagnosis: A Group-Based Trajectory Modeling Approach#361166Springer Nature OA
• Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial#370715HAL (France)
• Development of the Prostate Cancer Treatment Decision Framework: A Context-Specific Expansion of the Risk-As-Feelings Hypothesis#376328Scholar Commons
• Comparative analysis of second and third-generation nanobody-based CAR-NK cells targeting PSMA in prostate cancer immunotherapy: In silico and in vitro studies.#636323NCBI PubMed Central
• Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases.#9669PubMed
• Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer#238036bioRxiv / medRxiv
• Insurance Network Status and 1-Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non-Definitively Treated Prostate Cancer, 2010-2021.#265501NCBI PubMed Central
• Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)#657818Cornell eCommons
• MICHL-trial: Impact of Peritoneal Bladder Flap in RARP Patients on Lymphoceles#813600ClinicalTrials.gov
• Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy#836404ClinicalTrials.gov
• Training for Men Undergoing Androgen Deprivation Therapy.#842171ClinicalTrials.gov
• Protocol for the internet-based lifestyle intervention to eradicate obese frailty in prostate cancer survivors (iLIVE) randomized controlled trial: a type I hybrid effectiveness implementation trial.#154498NCBI PubMed Central
• Causal association and shared mechanisms between Graves' disease and prostate cancer: insights from Mendelian randomization, machine learning, and comprehensive bioinformatics.#376039PubMed
• The impact of different exercise modalities on health-related quality of life in patients with prostate cancer undergoing androgen deprivation therapy: a systematic review and network meta-analysis.#631005NCBI PubMed Central
• Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [(68)Ga]GaPSMA-PET/CT for [(177)Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).#340405NCBI PubMed Central
• Discovery of PIM-1 kinase inhibitors based on the 2,5-disubstituted 1,3,4-oxadiazole scaffold against prostate cancer: Design, synthesis, in vitro and in vivo cytotoxicity investigation#361966HAL (France)
• HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer#377974HAL (France)
• Extra-prostatic extension grading system: correlation with MRI features and integration of capsular enhancement sign for “enhanced” detection of T3a lesions#433531IRIS
• Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer#485136Europe PMC
• Synthesis and biological evaluation of benzimidazolyl phenylpropenones as selective anticancer agents in prostate colon and breast cancer models#156045HAL (France)
• Optimization of reaction conditions and process automation for [99mTc]Tc-PSMA-I&S preparation on a GAIA® synthesizer#194447HAL (France)
• Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysis#468403HAL (France)
• Barriers and Facilitators to Supportive Care Implementation in Advanced Disease Prostate Cancer Survivors: A Theory-Informed Scoping Review#406803Scholar Commons
• A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer#154693ClinicalTrials.gov
• Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence#841195ClinicalTrials.gov
• ProHealth: a co-designed online home-based healthy eating and exercise programme for men with prostate cancer treated with androgen deprivation therapy - a study protocol for a feasibility and preliminary efficacy randomised controlled trial.#135680NCBI PubMed Central
• Study to Monitor the Effects of Androgen Suppression Treatment on the Heart#846045ClinicalTrials.gov
• The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer.#156956NCBI PubMed Central
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors#825504ClinicalTrials.gov
• Glucosinolat- und Selen-angereicherter Brokkoli als funktionelles Lebensmittel zur Prävention von Prostatakrebs, Arbeitspaket 2, 3, 7 : Schlußbericht ... ; Vorhabensbezeichnung: Workpackage 2: Investigations of selenium- and isothiocyanate-enriched broccoli extracts and broccoli products ind prostate cancer cell lines in vitro ; Workpackage 3: Investigations of selenium- und isothiocyanateenriched broccoli extracts and broccoli products in prostate cancer xenograft models in vivo ; Workpage 7: Productions of optimised broccolie extract powder containing free sulforaphane for intervention studies ; Laufzeit/Berichtszeitraum: 01.08.2006 - 31.07.2010#129630DataCite
• Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial#167768Griffith Research Online
• Towards individualized treatment planning for PSMA-targeted radioligand therapy of advanced prostate cancer: from in silico determination of the relative biological effectiveness to image-based red bone marrow dosimetry / Mikhail Rumiantcev ; Betreuer: Guido Böning#661773Deutsche Nationalbibliothek
• First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.#309136NCBI PubMed Central
• A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)#802132ClinicalTrials.gov
• Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy#834994ClinicalTrials.gov
• Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy#836869ClinicalTrials.gov
• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors#806826ClinicalTrials.gov
• Don't Fear the Artificial Intelligence: A Systematic Review of Machine Learning for Prostate Cancer Detection in Pathology#394563BYU ScholarsArchive
• Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy#619986eScholarship
• ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)#201773ClinicalTrials.gov
• Oncologic outcomes in a contemporary "PROTEUS-like" cohort of high-risk prostate cancer treated with radical prostatectomy without neoadjuvant hormonal therapy / Can Aydogdu, Benso John, Clara Seizer, Frederik Kolligs, Iason Papadopoulos, Alexander Buchner, Elena K. Berg, Jozefina Casuscelli, Julie Steinestel, Roman Mayr, Matthias Heck, Christian G. Stief, Thilo Westhofen#783976Deutsche Nationalbibliothek
• A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe#800703ClinicalTrials.gov
• Salvage radiotherapy confers an overall survival advantage in biochemical recurrence of prostate cancer: evidence from the international PROMISE registry / Nika Guberina, Madeleine J. Karpinski, Maja Guberina, Sebastian Hoberück, Matthias Miederer, Tobias Hölscher, Isabel Rauscher, Matthias Eiber, Andrew Nguyen, Lela Theus, Matteo Bauckneht, Helen Scholtissek, Kambiz Rahbar, Jonathan Miksch, Daniele Antonio Pizzuto, Karolien Goffin, Caner Civan, Shima F. Reinwand, Andreas Stang, Jens Kleesiek, Anja Merkel-Jens, Lale Umutlu, Alfonso Santangelo, Timo F. W. Soeterik, Stephan Beintner-Skawran, Andrej Vondrak, Anders Bjartell, Laura Evangelista, Sazan Rasul, Marcin Miszczyk, Adrien Holzgreve, Gabriel T. Sheikh, Andrea Di Giorgio, Andrea Farolfi, Ken Herrmann, Boris Hadaschik, Wolfgang P. Fendler, Martin Stuschke#783931Deutsche Nationalbibliothek